Kimberly Chong

Array ( [id] => 6202986 [patent_doc_number] => 20110065772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'TREATMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/667007 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11129 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065772.pdf [firstpage_image] =>[orig_patent_app_number] => 12667007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753184 [patent_doc_number] => 20080161259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Inhibitory pellion nucleic acids' [patent_app_type] => utility [patent_app_number] => 11/821945 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161259.pdf [firstpage_image] =>[orig_patent_app_number] => 11821945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6150004 [patent_doc_number] => 20110021599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'METHODS AND COMPOSITIONS FOR INHIBITING OR REDUCING HAIR LOSS, ACNE, ROSACEA, PROSTATE CANCER, AND BPH' [patent_app_type] => utility [patent_app_number] => 12/303998 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 96 [patent_figures_cnt] => 96 [patent_no_of_words] => 51714 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 78 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021599.pdf [firstpage_image] =>[orig_patent_app_number] => 12303998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374833 [patent_doc_number] => 20090312394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Protection against and treatment of age related macular degeneration' [patent_app_type] => utility [patent_app_number] => 12/308342 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10778 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312394.pdf [firstpage_image] =>[orig_patent_app_number] => 12308342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225784 [patent_doc_number] => 20070255051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'siRNA targeting serine/threonine kinase 22B (STK22B)' [patent_app_type] => utility [patent_app_number] => 11/811929 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34268 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20070255051.pdf [firstpage_image] =>[orig_patent_app_number] => 11811929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344829 [patent_doc_number] => 20100248364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'SENSE OLOGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/303914 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10617 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20100248364.pdf [firstpage_image] =>[orig_patent_app_number] => 12303914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297094 [patent_doc_number] => 20090012020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Inhibiting formation of atherosclerotic lesions' [patent_app_type] => utility [patent_app_number] => 11/810344 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8754 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012020.pdf [firstpage_image] =>[orig_patent_app_number] => 11810344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6370557 [patent_doc_number] => 20100088775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'METHODS OF MODULATING EPITHELIAL-MESENCHYMAL TRANSITION AND MESENCHYMAL-EPITHELIAL TRANSITION IN CELLS AND AGENTS USEFUL FOR THE SAME' [patent_app_type] => utility [patent_app_number] => 12/302244 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 35395 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20100088775.pdf [firstpage_image] =>[orig_patent_app_number] => 12302244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404617 [patent_doc_number] => 20090239931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 11/748029 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 85627 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239931.pdf [firstpage_image] =>[orig_patent_app_number] => 11748029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465841 [patent_doc_number] => 20090326041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2' [patent_app_type] => utility [patent_app_number] => 12/299611 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137415 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0326/20090326041.pdf [firstpage_image] =>[orig_patent_app_number] => 12299611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570393 [patent_doc_number] => 20090253771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'INHIBITION OF GLIOTOXIN' [patent_app_type] => utility [patent_app_number] => 12/298798 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9001 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253771.pdf [firstpage_image] =>[orig_patent_app_number] => 12298798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772418 [patent_doc_number] => 08426374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-04-23 [patent_title] => 'Method for modifying myostatin expression' [patent_app_type] => utility [patent_app_number] => 11/744158 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 36 [patent_no_of_words] => 10918 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11744158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552868 [patent_doc_number] => 20090286854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'APTAMERS DIRECTED TO MUCI' [patent_app_type] => utility [patent_app_number] => 12/299596 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7283 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286854.pdf [firstpage_image] =>[orig_patent_app_number] => 12299596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046546 [patent_doc_number] => 20070265220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Methods and compositions for the specific inhibition of gene expression by double-stranded RNA' [patent_app_type] => utility [patent_app_number] => 11/797216 [patent_app_country] => US [patent_app_date] => 2007-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 31435 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265220.pdf [firstpage_image] =>[orig_patent_app_number] => 11797216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977627 [patent_doc_number] => 08071560 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor' [patent_app_type] => utility [patent_app_number] => 11/799225 [patent_app_country] => US [patent_app_date] => 2007-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 33 [patent_no_of_words] => 21321 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071560.pdf [firstpage_image] =>[orig_patent_app_number] => 11799225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600338 [patent_doc_number] => 20100292298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'METHOD AND REAGENTS FOR TREATING HEPATIC FIBROSIS AND INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/279984 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11109 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292298.pdf [firstpage_image] =>[orig_patent_app_number] => 12279984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13702 [patent_doc_number] => 07807649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Modulation of forkhead box O1A expression' [patent_app_type] => utility [patent_app_number] => 11/739017 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 37620 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807649.pdf [firstpage_image] =>[orig_patent_app_number] => 11739017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753161 [patent_doc_number] => 20080161236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'THERAPEUTIC NUCLEIC ACID-3\'-CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/735221 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11184 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161236.pdf [firstpage_image] =>[orig_patent_app_number] => 11735221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126418 [patent_doc_number] => 20070238689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'MODULATION OF GLUCAGON RECEPTOR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/697273 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31569 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238689.pdf [firstpage_image] =>[orig_patent_app_number] => 11697273 [rel_patent_id] =>[rel_patent_doc_number] =>)